Walleye Trading
ARRY

Walleye Trading’s Array Biopharma Inc ARRY Stock Holding History

Walleye Trading’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,900
Closed -$412K – 4699
2019
Q2 		$412K Buy
8,900
+4,100
+85% +$115K ﹤0.01% 2353
2019
Q1 		$117K Sell
4,800
-6,200
-56% -$129K ﹤0.01% 3379
2018
Q4 		$157K Buy
+11,000
New +$167K ﹤0.01% 3607

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Walleye Trading's ARRY Position: Q3 2019 in Review

Walleye Trading sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 78,038 shares — an estimated $3.62M sold.

Walleye Trading first reported a position in ARRY in Q3 2015 and held it in 5 quarters. The position peaked at $3.62M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Walleye Trading reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Walleye Trading sold 78,038 Array Biopharma Inc shares in Q3 2019, an estimated $3.62M.
  • Walleye Trading first reported a position in Array Biopharma Inc in Q3 2015 and held it in 5 quarters.
  • Walleye Trading's Array Biopharma Inc position peaked at $3.62M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Walleye Trading's 13F filing for Q3 2019, filed 14 Nov 2019.